119 filings
Page 2 of 6
8-K
8nhc 4z2leod35yyhyn9
2 Aug 22
Sage Therapeutics Announces Second Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
z226gk2f
14 Jul 22
In the Court of Chancery of the State of Delaware
4:08pm
8-K
2sdegrlb5tm
21 Jun 22
Departure of Directors or Certain Officers
4:41pm
8-K
4jm3uzcc6
13 Jun 22
Other Events
7:01am
8-K
vfqgo1w1 v25
1 Jun 22
Other Events
7:16am
8-K
u5f3v6o3q8n f5x4grm
3 May 22
Sage Therapeutics Announces First Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
fq8x6 mjoe1zs45lf
24 Feb 22
Sage Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
a4b6q8l t8dsvx39im1
16 Feb 22
Other Events
7:00am
8-K
a1s4 cvcp3q4
10 Jan 22
Regulation FD Disclosure
7:31am
8-K
aicop3zih j9v9n
1 Dec 21
Sage Therapeutics and Biogen Announce Positive, One-Year Zuranolone 50 mg Data in the Ongoing Open-Label SHORELINE Study in Patients with MDD
7:00am
8-K
gi7g0 6bvdmbkit
2 Nov 21
Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
7:30am
8-K
ep58nufj9r5xixa
19 Oct 21
Other Events
8:01am
8-K
vo98z8bzdh izi82oh
3 Aug 21
Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
7:01am
8-K
uizjw6
15 Jun 21
Other Events
6:50am
8-K
n5a54jz6
10 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
96b2b
4 May 21
Sage Therapeutics Announces First Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
7:14am
8-K
w4prx3ic4v33p5xl5
12 Apr 21
Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint
7:17am
8-K
ek19sgywjojm xc
18 Mar 21
Sage Therapeutics Announces Continued Positive Zuranolone Data for Both
6:55am
8-K
mbl8caqhlz4i mdruo94
17 Mar 21
Departure of Directors or Certain Officers
8:04am
8-K
yzwuh
24 Feb 21
Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
6:46am